Only 1 out of 3 adults are vaccinated against pertussis1
Despite ACIPa, CDCb, and AAFPc guidelines for Tdapd vaccination,2,3 only 1 in 3 adults received a Tdap vaccine.1
“Persons aged ≥ 19 years who previously have not received a dose of Tdap should receive a single dose of Tdap in place of decennial Tde booster dose.” - ACIP - 20202
Adacel can be given as repeat vaccination and is available in
prefilled syringes and vials made without natural rubber latex4
After the first and second dose of Adacel, the most frequently reported solicited reactions were pain, swelling, and erythema at the injection site; headache, body ache or muscle weakness, tiredness, myalgia, and malaise.
Other adverse reactions may occur. Vaccination with Adacel may not protect all individuals.
Over 150 Million doses distributed over a decade5
Help protect your patients as young as 10 years old4
Adacel is indicated for active booster immunization against tetanus, diphtheria, and pertussis. Adacel is approved for use in individuals 10 through 64 years of age.